These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 11342997

  • 1. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E, Bahnini A, Mouren X, Gamand S.
    Int Angiol; 2001 Mar; 20(1):58-65. PubMed ID: 11342997
    [Abstract] [Full Text] [Related]

  • 2. An evaluation of patients with severe intermittent claudication and the effect of treatment with naftidrofuryl.
    Moody AP, al-Khaffaf HS, Lehert P, Harris PL, Charlesworth D.
    J Cardiovasc Pharmacol; 1994 Mar; 23 Suppl 3():S44-7. PubMed ID: 7517477
    [Abstract] [Full Text] [Related]

  • 3. Treatment of stage II chronic arterial disease of the lower limbs with the serotonergic antagonist naftidrofuryl: results after 6 months of a controlled, multicenter study.
    Adhoute G, Andreassian B, Boccalon H, Cloarec M, Di Maria G, Lefebvre O, Mondine P, Plagnol P, Pointel JP, Quancard X.
    J Cardiovasc Pharmacol; 1990 Mar; 16 Suppl 3():S75-80. PubMed ID: 1369725
    [Abstract] [Full Text] [Related]

  • 4. Naftidrofuryl in quality of life (NIQOL). A Belgian study.
    D'Hooge D, Lehert P, Clement DL.
    Int Angiol; 2001 Dec; 20(4):288-94. PubMed ID: 11782694
    [Abstract] [Full Text] [Related]

  • 5. [Effect of naftidrofuryl on physiological walking distance in patients with intermittent claudication].
    Boccalon H, Lehert P, Mosnier M.
    Ann Cardiol Angeiol (Paris); 2001 Apr; 50(3):175-82. PubMed ID: 12555510
    [Abstract] [Full Text] [Related]

  • 6. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
    Nenci GG, Gresele P, Ferrari G, Santoro L, Gianese F, Mesoglycan Intermittent Claudication Group.
    Thromb Haemost; 2001 Nov; 86(5):1181-7. PubMed ID: 11816704
    [Abstract] [Full Text] [Related]

  • 7. Naftidrofuryl in intermittent claudication: a retrospective analysis.
    Lehert P, Comte S, Gamand S, Brown TM.
    J Cardiovasc Pharmacol; 1994 Nov; 23 Suppl 3():S48-52. PubMed ID: 7517478
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial--walking distance and microcirculation.
    De Sanctis MT, Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, Incandela L, Bucci M, Geroulakos G, Ramaswami G, Vasdekis S, Agus G, Bavera P, Ippolito E.
    Angiology; 2002 Nov; 53 Suppl 1():S7-12. PubMed ID: 11865838
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effects of sublingual glyceryl trinitrate on walking distance in patients with intermittent claudication. A randomised, doubled-blind, placebo-controlled, cross-over study.
    Heer R, Walker S, MacSweeney S.
    Curr Med Res Opin; 2001 Nov; 17(2):113-5. PubMed ID: 11759179
    [Abstract] [Full Text] [Related]

  • 12. Naftidrofuryl can enhance the quality of life in patients with intermittent claudication.
    Spengel F, Brown TM, Poth J, Lehert P.
    Vasa; 1999 Aug; 28(3):207-12. PubMed ID: 10483329
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Naftidrofuryl: a review of its use in the treatment of intermittent claudication.
    Goldsmith DR, Wellington K.
    Drugs Aging; 2005 Aug; 22(11):967-77. PubMed ID: 16323973
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Evaluation of the efficacy and tolerance of naftidrofuryl in patients presenting with exertional angina. Multicenter double-blind versus placebo study].
    Hirsch JL, Bensoussan JJ, Mosnier M, Lehert P.
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):137-45. PubMed ID: 12555338
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Naftidrofuryl in arterial occlusive disease. Controlled multicenter double-blind study with oral administration].
    Maass U, Amberger HG, Böhme H, Diehm C, Dimroth H, Heidrich H, Heinrich F, Hirche H, Mörl H, Müller-Bühl U.
    Dtsch Med Wochenschr; 1984 May 11; 109(19):745-50. PubMed ID: 6373217
    [Abstract] [Full Text] [Related]

  • 20. Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study.
    Brevetti G, Perna S, Sabbá C, Martone VD, Condorelli M.
    J Am Coll Cardiol; 1995 Nov 15; 26(6):1411-6. PubMed ID: 7594063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.